# Cord Blood Transplantation for Patients With Cancer

> **NCT01359254** · PHASE2 · TERMINATED · sponsor: **University of Chicago** · enrollment: 1 (actual)

## Conditions studied

- Hematological Disease

## Interventions

- **DRUG:** Melphalan
- **DRUG:** Fludarabine
- **DRUG:** Antithymocyte Globulin (ATG)
- **DRUG:** Busulfan
- **DRUG:** Total Body Irradiation (TBI)

## Key facts

- **NCT ID:** NCT01359254
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2011-09
- **Final completion:** 2012-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** did not accrue enough patients.
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01359254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01359254, "Cord Blood Transplantation for Patients With Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01359254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*